Atara Biotherapeutics, Inc. (ATRA)
Market Closed
1 Sep, 20:00
$
9. 02
+0.12
+1.3483%
$
82.89M Market Cap
- P/E Ratio
- Div Yield
51,942 Volume
-2.6 Eps
$ 8.9
Previous Close 
Want to track ATRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Atara Biotherapeutics, Inc. (ATRA) Statistics
Valuation metrics
Market Cap 82.89M
Enterprise value 89.55M
Trailing P/E (ttm) -7.8
Forward P/E 5.99
PEG ratio 0.05
Price/Sales (ttm) 13.38
Price/Book (mrq) -3.74
Enterprise Value/Revenue 14.46
Enterprise Value/EBITDA -6.56
Overview
Shares outstanding 8.51M
Float 4.74M
Shares short 306.09K
% Held by insiders 0.17%
% Held by institutions 0.49%
Average volume (10 days) 15.35K
Average volume (90 days) 78.06K
Price summary
52-Week low 3.92
52-Week high 19.14
Beta -0.33
50-Day moving average 8.22
200-Day moving average 6.51
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 20 Jun 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -2.69%
Operating margin -2.3%
Operational effectiveness
Return on assets -0.79%
Return on equity 0.45%
Income Statement
Revenue (ttm) 23.14M
Revenue per share (ttm) 0.41
Quarterly revenue growth (yoy) -0.99%
Gross profit (ttm) -2.7M
EBITDA 38.63M
Net income to common (ttm) -9.47M
Diluted EPS (ttm) -1.11
Quarterly earnings growth (yoy) -0.99%
Balance Sheet
Total cash (mrq) 8.36M
Total cash per share (mrq) 0.66
Total debt (mrq) 9.08M
Total Debt/Equity (mrq) -0.27
Current ratio (mrq) 1.98%
Book value per share (mrq) -2.46
Cash Flow
Cash flow statement -25.88M
Levered free cash flow (LFCF) -6.39M
